25.09.2014
- US-based Acorda Therapeutics has acquired privately held Civitas Therapeutics for $525 million to gain access to a Parkinson's disease drug in late-stage development. With the buy...
31.01.2011
- Major drug makers are looking for products by purchasing smaller companies, creating many value opportunities, Barron's reported in its Jan. 31 edition. Among the companies that...
